Highlights
- •A Bayesian meta-analysis method, which is more welcome than traditional meta-analysis, has so far not been performed in patients with DKD.
- •This analysis shows that ACEIs and ARBs generally have not dissimilar impacts on renoprotective outcomes.
- •Neither ACEIs nor ARBs can reduce the risk for cardiovascular death or all-cause mortality in DKD.
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to European Journal of Internal MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease.Kidney Int Suppl. 2012; 3: 1-150
- Am J Kidney Dis. 2012; 60: 850-886
- Effects of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists on mortality and renal outcomes in diabetic nephropathy: systematic review.BMJ. 2004; 329: 828
- Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on All-Cause Mortality and Renal Outcomes in Patients with Diabetes and Albuminuria: a Systematic Review and Meta-Analysis.Kidney Blood Press Res. 2018; 43: 768-779
- Impact of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers on renal and mortality outcomes in people with Type 2 diabetes and proteinuria.Diabet Med. 2020; 37: 44-52
- Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the progression of diabetic kidney disease.Cochrane Database Syst Rev. 2006; 2006 (CD006257)
- The Cochrane Collaboration's tool for assessing risk of bias in randomised trials.BMJ. 2011; 343: d5928
Dias S., Welton N.J., Sutton A.J., Ades A.E.. NICE DSU technical support document 2: A generalised linear modelling framework for pairwise and network meta-analysis of randomised controlled trials, May 2011; last updated September 2016; available from http://www.nicedsu.org.uk.
- Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial.J Clin Epidemiol. 2011; 64: 163-171
- Association of renin-angiotensin system inhibitors with long-term outcomes in patients with systolic heart failure and moderate-to-severe kidney function impairment.Eur J Intern Med. 2019; 62: 58-66
Article info
Publication history
Published online: November 26, 2020
Accepted:
November 16,
2020
Received in revised form:
November 11,
2020
Received:
October 20,
2020
Identification
Copyright
© 2020 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.
